Chemoinformaics analysis of P-Mentha-3-En-7-Ol
| Molecular Weight | 154.253 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 6 |
| Exact Molecular Weight | 154.136 | nRing | 1 |
| Solubility: LogS | -2.372 | nHRing | 0 |
| Solubility: LogP | 2.767 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.605 |
| Synth | 3.317 |
| Natural Product Likeliness | 1.728 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.199 |
| MDCK | 0.0000192 |
| BBB | 0.96 |
| PPB | 0.859486 |
| VDSS | 1.312 |
| FU | 0.0835807 |
| CYP1A2-inh | 0.563 |
| CYP1A2-sub | 0.688 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.787 |
| CYP2c9-inh | 0.057 |
| CYP2c9-sub | 0.508 |
| CYP2d6-inh | 0.095 |
| CYP2d6-sub | 0.501 |
| CYP3a4-inh | 0.054 |
| CYP3a4-sub | 0.264 |
| CL | 9.539 |
| T12 | 0.656 |
| hERG | 0.004 |
| Ames | 0.015 |
| ROA | 0.016 |
| SkinSen | 0.099 |
| Carcinogencity | 0.909 |
| EI | 0.916 |
| Respiratory | 0.047 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.943017 |